Biochemistry, Genetics and Molecular Biology
Adherens Junction
13%
Anticancer
31%
Antisense RNA
31%
Astrocyte
31%
Biogenesis
31%
Cancer Cell
44%
Cancer Specific Survival
22%
Carcinogenesis
51%
Cell Proliferation
22%
Disease Free Survival
65%
down Regulation
94%
E2F1
31%
Epidermal Growth Factor Receptor
62%
Event Free Survival
31%
Fibroblast
35%
Galectin-3
31%
Gene Expression
15%
Gene Expression Profiling
31%
Gene Ontology
13%
Gene Signature
62%
Gene Therapy
15%
Hemocyte
31%
Hub Genes
13%
Integrin
31%
Matrix Metalloproteinase
31%
Medline
25%
Mesenchymal-Epithelial Transition
19%
Microarrays
10%
MiR-132
62%
Multivariate Analysis
39%
Natural Language Processing
31%
Neurotrophin
13%
Observational Study
31%
Overall Survival
76%
P53
31%
Progression Free Survival
64%
Protein Expression
31%
Protein-Protein Interaction
41%
Quantitative Reverse Transcription Polymerase Chain Reaction
78%
Recurrence Free Survival
68%
Reverse Transcription
15%
Signal Transduction
81%
Solution and Solubility
31%
Tissue Microarray
31%
Tumor Volume
31%
Vascular Endothelial Growth Factor
31%
Vasoactive Intestinal Peptide
14%
VEGF Signaling
13%
Vimentin
31%
Web of Science
25%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
15%
Biocompatibility
31%
Biological Marker
44%
Breast Cancer
10%
Carcinogenesis
24%
Clinical Trial
10%
Colorectal Carcinoma
10%
Combination Therapy
31%
Complementary RNA
31%
Digestive System Cancer
31%
Disease Free Survival
31%
Disease Specific Survival
10%
Distant Metastasis
15%
Drug Carrier
31%
Drug Delivery System
31%
Drug Development
31%
Epidermal Growth Factor Receptor
35%
Esophageal Squamous Cell Carcinoma
10%
Event Free Survival
20%
Formaldehyde
18%
Galectin 3
31%
Gallbladder Carcinoma
10%
Gastrointestinal Carcinoma
10%
Immunotherapy
15%
Integrin
31%
Liver Carcinogenesis
31%
Liver Cell Carcinoma
88%
Lymph Node Metastasis
19%
Malignant Neoplasm
100%
Metastatic Breast Cancer
31%
microRNA 132
31%
microRNA 34a
31%
Nasopharynx Carcinoma
31%
Neoplasm
93%
Non Small Cell Lung Cancer
62%
Observational Study
31%
Overall Survival
30%
Pancreas Adenocarcinoma
10%
Primary Tumor
10%
Progression Free Survival
20%
Protein P53
31%
Random Effects Model
9%
Recurrence Free Survival
31%
Solid Malignant Neoplasm
31%
Squamous Cell Carcinoma
15%
Stomach Carcinoma
10%
Systemic Administration
31%
Tumor Growth
12%
Vasoactive Intestinal Polypeptide
14%
Vimentin
31%
Medicine and Dentistry
Anticarcinogen
20%
Biopsy Sample
15%
Breast Cancer
10%
Cancer Cell
37%
Cancer Immunotherapy
10%
Cancer Therapy
31%
Carcinogenesis
26%
Carcinoma
15%
Cell Communication
23%
Cell Component
31%
Diagnosis
20%
Doxorubicin
10%
Drug Delivery System
31%
Epidermal Growth Factor Receptor
31%
Extracellular Matrix
10%
Formaldehyde
18%
Galectin 3
31%
Ganglioglioma
31%
Gene Expression Profiling
31%
Gene Therapy
15%
Hepatocellular Carcinoma
94%
Immunohistochemistry
15%
Immunotherapy
10%
Integrin
31%
Language Processing
15%
Lymph Node Metastasis
15%
Malignant Neoplasm
89%
Mesenchymal-Epithelial Transition
15%
Meta-Analysis
36%
Metastatic Breast Cancer
31%
Metastatic Carcinoma
42%
microRNA 132
31%
Nasopharynx Carcinoma
31%
Natural Childbirth
10%
Natural Product
10%
Neoplasm
15%
Overall Survival
12%
Paclitaxel
10%
Protein P53
31%
Protein-Protein Interaction
12%
Reproducibility
10%
Rigor
10%
Side Effect
10%
Signal Transduction
22%
Stromal Cell
31%
The Cancer Genome Atlas
18%
Therapeutic Agent
31%
Tissue Microarray
31%
Tumor Microenvironment
33%
Vasculotropin
31%
